Literature DB >> 21390458

[Prevalence of hospital admission due to adverse drug reaction in Salvador, Bahia].

Antonio Carlos Beisl Noblat1, Lúcia Araújo Costa Beisl Noblat, Leonardo Augusto Kister de Toledo, Pablo de Moura Santos, Márcio Galvão Guimarães de Oliveira, Gustavo Mustafá Tanajura, Silviana Ultchak Spinola, José Ricardo Madureira de Almeida.   

Abstract

OBJECTIVE: To determine the prevalence of hospital admissions due to ADR in Salvador, Bahia and their outcomes.
METHODS: All patients admitted in four Sentinel Hospital (ANVISA) in Salvador-Ba were evaluated and followed to determine the prevalence of admissions due to ADR and their outcomes from April to December 2007. Cases were validated by 03 algorithms. The drugs were classified by Anatomical-Therapeutic-Chemical Classification, organs and systems affected by the WHO criteria and severity seconds Pearson et al. Type of ADR was analyzed by Rawlins and Thompson.
RESULTS: The prevalence of ADR admission was 0.5% and adjusted for exposed was 2.1%, with 316 cases. Average of hospitalization due to ADR was 12.3 days. Younger and older accounted for 28.8% and 31.1% of patients. Females and blacks were 60% of cases. Main pharmacologic groups were antineoplastics, antibiotics and diuretics, affecting skin, gastrointestinal and hematologic systems. Around 70% of the ADR was validated as defined. ADR of type A was 80% and 90% recovered, and one death (0.5%).
CONCLUSION: The prevalence of ADR admission was similar to those described in the literature and only one patient died. As this is the first national study will form the basis for future investigations.

Entities:  

Mesh:

Year:  2011        PMID: 21390458

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  3 in total

1.  Mortality from adverse drug reactions in adult medical inpatients at four hospitals in South Africa: a cross-sectional survey.

Authors:  Johannes P Mouton; Ushma Mehta; Andy G Parrish; Douglas P K Wilson; Annemie Stewart; Christine W Njuguna; Nicole Kramer; Gary Maartens; Marc Blockman; Karen Cohen
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

Review 2.  Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors.

Authors:  Mulugeta Tarekegn Angamo; Leanne Chalmers; Colin M Curtain; Luke R E Bereznicki
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.606

3.  Increase of 10% in the Rate of Adverse Drug Reactions for Each Drug Administered in Hospitalized Patients.

Authors:  Marisa Rosimeire Ribeiro; Antonio Abílio Motta; Luiz Augusto Marcondes-Fonseca; Jorge Kalil-Filho; Pedro Giavina-Bianchi
Journal:  Clinics (Sao Paulo)       Date:  2018-02-08       Impact factor: 2.365

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.